Is neoadjuvant therapy the answer to adenocarcinoma of the esophagus?

American Journal of Surgery

Volumn 186, Issue 3, 2003, Pages 296-300

  Burak Jr , William E ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Adenocarcinoma; Esophagus; Neoadjuvant therapy

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; VINBLASTINE;

ADJUVANT CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; ESOPHAGUS CARCINOMA; HUMAN; META ANALYSIS; PRIORITY JOURNAL; REVIEW; ADENOCARCINOMA; ADJUVANT THERAPY; ESOPHAGUS TUMOR; MORTALITY; MULTIMODALITY CANCER THERAPY;

ADENOCARCINOMA; CLINICAL TRIALS; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; HUMANS; NEOADJUVANT THERAPY;

EID: 0141612867     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(03)00222-8     Document Type: Note

References (32)

1. Daly J.M., Karnell L.H., Menck H.R. National cancer data base report on esophageal carcinoma. Cancer. 78:1996;1820-1828.
2. Bytzer P., Christensen P.B., Damkier P., et al. Adenocarcinoma of the esophagus and Barrett's esophagus a population-based study. Am J Gastroenterol. 94:1999;86-91.
3. Devesa S.S., Blot W.J., Fraumeni J.F. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 83:1998;2049-2053.
4. Locke G.R., Talley N.J., Fett S.L., et al. Prevalence and clinical spectrum of gastrointestinal reflux a population-based study in Olmsted County, Minnesota. Gastroenterology. 112:1997;1448-1456.
5. Blot W.J., Devasa S.S., Fraumeni J.F. Continuing climb in rates of esophageal adenocarcinoma an update. JAMA. 270:1993;1320.
6. Pera M., Cameron A.J., Trastek V.F., et al. Increasing incidence of adenocarcinoma of the esophagus and esophageal junction. Gastroenterology. 104:1993;510-513.
7. Jemal A., Thomas A., Murray T., Thun M. Cancer statistics, 2002. Cancer J Clin. 52:2002;23-47.
8. Spechler S.J., Goyal R.K. Barrett's esophagus. N Engl J Med. 315:1986;362-371.
9. Haggitt R.C. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol. 25:1994;982-993.
10. Winter C., Spurling T.J., Chobabian S.J., et al. Barrett's esophagus. A prevalent occult complication of gastroesophageal reflux disease. Gastroenterology. 92:1987;118-124.
11. Miros M., Kerlin P., Walker N. Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus. Gut. 32:1991;1441-1446.
12. Hameeteman W., Tytgat G.N., Houthoff H.J., van den Tweel J.G. Barrett's esophagus development of dysplasia and adenocarcinoma. Gastroenterology. 96:1989;1249-1256.
13. Hamilton SR, Smith RR. The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus. Am J Clin Pathol 1987:301-12.
14. Richter J.E. Importance of bile reflux in Barrett's esophagus. Dig Dis. 18:2000;208-216.
15. Caldwell M.T., Lawlor P., Byrne P.J., et al. Ambulatory oesophageal bile reflus monitoring in Barrett's oesophagus. Br J Surg. 82:1995;657-660.
16. Vaezi M.F., Richter J.E. Role of acid and duodeno-gastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology. 111:1996;1192-1199.
17. Dulai G.S., Guha S., Kahn K.L., et al. Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma a systematic review. Gastroenterology. 122:2002;26-33.
18. Orringer M.B., Marshall B., Iannettoni M.D. Transhiatal esophagectomy clinical experience and refinements. Ann Surg. 230:1999;392-403.
19. Hagen J.A., DeMeester S.R., Peters J.H., et al. Curative resection for esophageal carcinoma analysis of 100 en bloc esophagectomies. Ann Surg. 234:2001;520-530.
20. Alktori N., Skinner D. Should en bloc esophagectomy be the standard of care for esophageal carcinoma? Ann Surg. 234:2001;581-587.
21. Kelsen D.P., Ginsberg R., Pajak T.F. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med. 339:1998;1979-1984.
22. Urschel JD, Vasan H, Blewitt CJ. A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for respectable esophageal cancer. Am J Surg 2002;274-9.
23. Walsh T.N., Noonan N., Holywood D., et al. A comparison of multimodality therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 335:1996;462-467.
24. Hulscher J.B., van Sandick J.W., de Boer A.G., et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med. 347:2002;1662-1669.
25. Orringer M.B. Transhiatal esophagectomy without thoracotomy for carcinoma of the esophagus. Ann Surg. 200:1984;282-288.
26. Urschel J.D. Oesophagectomy volume and centralization of cancer surgery. J R Coll Surg Edinburgh. 44:1999;65.
27. Forastiere A.A., Orringer M.B., Perez-Tamayo C., et al. Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus final report. J Clin Oncol. 11:1993;1118-1123.
28. Posner M.C., Gooding W.E., Landreneau R.J., et al. Preoperative chemoradiotherapy for carcinoma of the esophagus and gastroesophageal junction. Cancer J Sci Am. 4:1998;237-246.
29. Adelstein D.J., Rice T.W., Becker M., et al. Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery for patients with esophageal carcinoma. Cancer. 80:1997;1011-1020.
30. Bates B.A., Detterbeck F.C., Bernard S.A., et al. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. J Clin Oncol. 14:1996;156-163.
31. Laterza E., de Manzoni G., Guglielmi A., et al. Endoscopic ultrasonography in the staging of esophageal carcinoma after preoperative radiotherapy and chemotherapy. Ann Thorac Surg. 67:1999;1466-1469.
32. Urba S.G., Orringer M.B., Turrisi A., et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol. 19:2001;305-313.